Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

SQZ Biotechnologies - Stock Split History | SQZ

Stock split history for SQZ Biotechnologies since 2023. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
  
SQZ Biotechnologies Annual Stock Splits
SQZ Biotechnologies Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.018B $0.021B
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $142.352B 8.79
GSK (GSK) United Kingdom $74.112B 9.29
Bio-Rad Laboratories (BIO.B) United States $13.735B 32.61
QIAGEN (QGEN) Netherlands $10.509B 19.47
Ginkgo Bioworks Holdings (DNA) United States $2.632B 0.00
Arcus Biosciences (RCUS) United States $1.286B 0.00
Biohaven (BHVN) United States $0.975B 0.00
Emergent Biosolutions (EBS) United States $0.406B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.147B 0.00
Enzo Biochem (ENZ) United States $0.108B 0.00
Gelesis Holdings (GLS) United States $0.012B 0.00